Testing rimegepant for migraine—time to revise the trial design?
Testing rimegepant for migraine—time to revise the trial design?
About this item
Full title
Testing rimegepant for migraine—time to revise the trial design?
Author / Creator
Publisher
London: Elsevier Ltd
Journal title
The Lancet (British edition), 2020-06, Vol.395 (10241), p.1901-1901
Language
English
Formats
Publication information
Publisher
London: Elsevier Ltd
Subjects
More information
Alternative Titles
Full title
Testing rimegepant for migraine—time to revise the trial design?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2415836425
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2415836425
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(20)30241-5
How to access this item
Log in as a Library member
